Vicorda ApS

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Vicorda ApS - overview

Established

2016

Location

-, -, Denmark

Primary Industry

Healthcare IT

About

Based in Denmark, Vicorda ApS specializes in health management solutions that integrate prevention and workplace initiatives, enhancing overall health outcomes for corporate clients across Europe. Vicorda ApS, founded in 2016 in Denmark, focuses on delivering health management solutions that cater to corporate clients. The company was established by Anders Becker and Daniel Olsen. In June 2025, Max Matthiessen AB acquired Vicorda ApS, although financial terms of the deal were not disclosed.


Vicorda offers a comprehensive suite of health management solutions that integrates prevention, well-being, and proactive workplace initiatives. The core product, VICORDA®, serves as a modular and flexible platform designed for corporate clients and end-users, facilitating strategic health and prevention initiatives. Its key functionalities include health screening modules, symptom checkers, illness checkers, and advisory services aimed at improving health outcomes. Primarily serving customers in the insurance, pension, and healthcare sectors across Europe, the platform supports over 2.


5 million users and features multilingual capabilities along with API integrations for enhanced connectivity. In the most recent financial year 2024, Vicorda generated a revenue of USD 1. 66 mn, with an EBITDA of USD 842,685. 7.


The company generates revenue through subscription-based services and partnerships, providing customized health solutions that can be part of integrated client systems, tailored to specific client requirements. Following its acquisition by Max Matthiessen AB on June 2, 2025, Vicorda plans to enhance its offerings to strengthen market presence. The acquisition aims to leverage Vicorda's health management solutions to expand into new markets. Future initiatives will focus on launching new products that support strategic health initiatives, aligning with Max Matthiessen AB's goal of expanding its service portfolio.


Current Investors

Max Matthiessen AB

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Application Integration Software

Website

www.vicorda.com

Verticals

HealthTech, Mobile Apps

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Vicorda ApS - financials

Fiscal Year EndedDec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue (USD)----------
% Revenue Growth (YoY)----------
EBITDA (USD)(34,789)530,4261,148,4141,474,4651,672,0634,104,5654,919,276---
Operating Income (USD)(370,789)525,2791,135,0201,447,4981,645,0964,080,9494,910,860---
Operating Margin----------
% EBITDA Margin----------
NET Income (USD)7,170402,936875,5721,114,6901,252,7343,313,3673,768,569---
% Net Margin----------

Vicorda ApS - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedVicorda ApS-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.